vs
LXP Industrial Trust（LXP）与SOLENO THERAPEUTICS INC（SLNO）财务数据对比。点击上方公司名可切换其他公司
LXP Industrial Trust的季度营收约是SOLENO THERAPEUTICS INC的1.3倍（$86.7M vs $66.0M），SOLENO THERAPEUTICS INC净利率更高（39.4% vs 33.2%，领先6.2%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
索雷诺治疗是一家临床阶段生物制药企业，专注于开发针对罕见内分泌、代谢及神经发育疾病的创新疗法，核心在研药物用于治疗普拉德-威利综合征，服务覆盖北美、欧盟等地区的罕见病患者群体。
LXP vs SLNO — 直观对比
营收规模更大
LXP
是对方的1.3倍
$66.0M
净利率更高
SLNO
高出6.2%
33.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $66.0M |
| 净利润 | $28.8M | $26.0M |
| 毛利率 | 81.5% | 98.3% |
| 营业利润率 | 34.6% | 33.5% |
| 净利率 | 33.2% | 39.4% |
| 营收同比 | -14.0% | — |
| 净利润同比 | — | 134.0% |
| 每股收益（稀释后） | — | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPSLNO
| Q4 25 | $86.7M | — | ||
| Q3 25 | $86.9M | $66.0M | ||
| Q2 25 | $87.7M | $32.7M | ||
| Q1 25 | $88.9M | — | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $85.6M | — | ||
| Q2 24 | $85.8M | — | ||
| Q1 24 | $86.3M | — |
净利润LXPSLNO
| Q4 25 | $28.8M | — | ||
| Q3 25 | $36.3M | $26.0M | ||
| Q2 25 | $29.1M | $-4.7M | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $5.4M | — | ||
| Q1 24 | $-269.0K | — |
毛利率LXPSLNO
| Q4 25 | 81.5% | — | ||
| Q3 25 | 82.3% | 98.3% | ||
| Q2 25 | 81.9% | 97.9% | ||
| Q1 25 | 80.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 82.5% | — | ||
| Q2 24 | 82.0% | — | ||
| Q1 24 | 82.4% | — |
营业利润率LXPSLNO
| Q4 25 | 34.6% | — | ||
| Q3 25 | 50.4% | 33.5% | ||
| Q2 25 | 33.7% | -20.0% | ||
| Q1 25 | 21.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 6.9% | — | ||
| Q1 24 | 1.0% | — |
净利率LXPSLNO
| Q4 25 | 33.2% | — | ||
| Q3 25 | 41.7% | 39.4% | ||
| Q2 25 | 33.2% | -14.4% | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | 6.3% | — | ||
| Q1 24 | -0.3% | — |
每股收益（稀释后）LXPSLNO
| Q4 25 | — | — | ||
| Q3 25 | $0.12 | $0.47 | ||
| Q2 25 | $0.09 | $-0.09 | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $498.9M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $2.0B | $494.8M |
| 总资产 | $3.5B | $599.9M |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资LXPSLNO
| Q4 25 | $170.4M | — | ||
| Q3 25 | $229.7M | $498.9M | ||
| Q2 25 | $71.0M | $286.8M | ||
| Q1 25 | $70.9M | — | ||
| Q4 24 | $101.8M | — | ||
| Q3 24 | $55.0M | — | ||
| Q2 24 | $48.7M | — | ||
| Q1 24 | $293.8M | — |
总债务LXPSLNO
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LXPSLNO
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | $494.8M | ||
| Q2 25 | $2.1B | $240.1M | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.2B | — |
总资产LXPSLNO
| Q4 25 | $3.5B | — | ||
| Q3 25 | $3.7B | $599.9M | ||
| Q2 25 | $3.7B | $332.3M | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $4.2B | — |
负债/权益比LXPSLNO
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $43.5M |
| 自由现金流经营现金流 - 资本支出 | — | $43.5M |
| 自由现金流率自由现金流/营收 | — | 65.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 6.56× | 1.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LXPSLNO
| Q4 25 | $188.7M | — | ||
| Q3 25 | $63.5M | $43.5M | ||
| Q2 25 | $44.3M | $-12.6M | ||
| Q1 25 | $39.0M | — | ||
| Q4 24 | $211.2M | — | ||
| Q3 24 | $64.6M | — | ||
| Q2 24 | $38.5M | — | ||
| Q1 24 | $38.9M | — |
自由现金流LXPSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率LXPSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度LXPSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率LXPSLNO
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | 1.67× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
